Pax6 regulates proliferation and apoptosis of human retinoblastoma cells

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 7, 2011, Pages 4560-4570

  Bai, Shu wei ^a   Li, Bin ^a   Zhang, Hao ^a   Jonas, Jost B ^b   Zhao, Bo wen ^a   Shen, Ling ^a   Wang, Yi chen ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYCLIN D1; CYCLIN DEPENDENT KINASE 1; PROTEIN P21; PROTEIN P27; TRANSCRIPTION FACTOR PAX6; EYE PROTEIN; HOMEODOMAIN PROTEIN; PAIRED BOX TRANSCRIPTION FACTOR; REPRESSOR PROTEIN; RNA; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; GENE; GENE FUNCTION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NICK END LABELING; PAX6 GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETINOBLASTOMA; UPREGULATION; WESTERN BLOTTING; BIOSYNTHESIS; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; RETINA TUMOR; TUMOR CELL CULTURE;

APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; EYE PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HOMEODOMAIN PROTEINS; HUMANS; PAIRED BOX TRANSCRIPTION FACTORS; POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; RETINAL NEOPLASMS; RETINOBLASTOMA; RNA, NEOPLASM; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 80052346365     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5487     Document Type: Article

References (27)

1. Gatta G, Capocaccia R, Coleman MP, Ries LA, Berrino F. Childhood cancer survival in Europe and the United States. Cancer. 2002;95: 1767-1772.
2. Chang CY, Ghiou TJ, Hwang B, Bay LY, Hsu WM, Hsieh YL. Retinoblastoma in Taiwan: survival rate and prognostic factors. Jpn J Ophthalmol. 2006;50:242-249.
3. Kivelä T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93:1129-1131.
4. Naseripour M, Nazari H, Bakhtiari P, Modarres-Zadeh M, Vosough P, Ausari. Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival: clinical science. Br J Ophthalmol. 2009;93:28-32.
5. MacCarthy A, Draper GJ, Steliarova-Foucher E, Kingston JE. Retinoblastoma incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42:2092-2102.
6. Cillo C, Faiella A, Cantile M, Boncinelli E. Homeobox genes and cancer. Exp Cell Res. 1999;248:1-9.
7. Lauderdale JD, Wilensky JS, Oliver ER, Walton DS, Glaser T. 3' deletions cause aniridia by preventing PAX6 gene expression. Proc Natl Acad Sci U S A. 2000;97:13755-13759.
8. Buttiglieri S, Deregibus MC, Bravo S, et al. Role of Pax2 in apoptosis resistance and proinvasive phenotype of Kaposi's sarcoma cells. J Biol Chem. 2004;279:4136-4143.
9. Lagergren A, Manetopoulos C, Axelson H, Sigvardsson M. Neuroblastoma and pre-B lymphoma cells share expression of key transcription factors but display tissue restricted target gene expression. BMC Cancer. 2004;4:80.
10. Muratovska AH, Zhou CH, He SH, et al. Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene. 2003;22:7989-7997.
11. Yamaoko T, Yano M, Yamada T, et al. Diabetes and pancreatic tumors in transgenic mice expressing Pax6. Diabetologia. 2000;43:332-339.
12. Larsson LI, St.-Onge L, Hougaard DM, et al. Pax4 and Pax6 regulate gastrointestinal endocrine cell development. Mech Dev. 1998;79: 153-159.
13. Mayes DA, Hu Y, Teng Y, et al. PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene. Cancer Res. 2006;66:9809-9817.
14. Shyr CR, Tsai MY, Yeh S, et al. Tumor suppressor Pax6 functions as androgen receptor co-repressor to inhibit prostate cancer growth. Prostate. 2010;70:190-199.
15. Ouyang J, Shen YC, Yeh LK, et al. Pax6 overexpression suppresses cell proliferation and retards the cell cycle in corneal epithelial cells. Invest Ophthalmol Vis Sci. 2006;47:2397-2407.
16. Hsieh YW, Yang XJ. Dynamic Pax6 expression during the neurogenic cell cycle influences proliferation and cell fate choices of retinal progenitors. Neural Dev. 2009;4:32.
17. Madhavan M, Haynes TL, Frisch NC, et al. The role of Pax-6 in lens regeneration. Proc Natl Acad Sci U S A. 2006;103:14848-14853.
18. Cvekl A, Kashanchi F, Brady JN, Piatigorsky J. Pax-6 interactions with TATA-box-binding protein and retinoblastoma protein. Invest Ophthalmol Vis Sci. 1999;40:1343-1350.
19. Singh RP, Dhanalskshmi S, Agarwal R. Phytochemicals as cell cycle modulators: a less toxic approach in halting human cancer. Cell Cycle. 2002;1:156-161.
20. Wikman H, Kettunen E. Regulation of the G1/S-phase of the cell cycle and alterations in the RB pathway in human 500 lung cancer. Expert Rev Anticancer Ther. 2006;6:515-530.
21. Kase S, Yoshida K, Ohgami K, et al. Expression of p27(KIP1) and cell proliferation in human retina and retinoblastoma. Anticancer Res. 2005;25:3843-3846.
22. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science. 1994;266:1821-1828.
23. Yuan J, Yan R, Kramer A, et al. CyclinB1 depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene. 2004;23:5843-5852.
24. Drago-Ferrante R, Santulli A, Di Fiore R, et al. Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1. Int J Oncol. 2008;33:677-687.
25. Jänicke RU, Sohn D, Essmann F, Schulze-Osthoff K. The multiple battles fought by anti-apoptotic p21. Cell Cycle. 2007;6:407-413.
26. Audo I, Darjatmoko SR, Schlamp CL, et al. Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma. Invest Ophthalmol Vis Sci. 2003;44:4192-4199.
27. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol. 2003;13: 65-70.